blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2425001

EP2425001 - COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.02.2017
Database last updated on 31.08.2024
FormerGrant of patent is intended
Status updated on  02.11.2016
Most recent event   Tooltip17.02.2017Application deemed to be withdrawnpublished on 22.03.2017  [2017/12]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2012/10]For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200 / US
Inventor(s)01 / ANDERSON, Joseph
c/o University of California, Davis
One Shields Avenue
Davis, California 95616 / US
02 / BAUER, Gerhard
c/o University of California, Davis
One Shields Avenue
Davis, California 95616 / US
 [2016/20]
Former [2012/10]01 / ANDERSON, Joseph
c/o University of California, Davis
One Shields Avenue
Davis, California 95616 / US
02 / BAUER, Gerhard
c/o University of California, Davis
One Shields Avenue
Davis, California 95616 / US
03 / NOLTA, Jan A.
c/o University of California, Davis
One Shields Avenue
Davis, California 95616 / US
Representative(s)Teall, Charlotte, et al
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2012/13]Teall, Charlotte, et al
Forrester & Boehmert
SkyGarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2012/10]Teall, Charlotte
Forrester & Boehmert
Pettenkoferstrasse 20-22
80336 Munich / DE
Application number, filing date10770370.429.04.2010
WO2010US33042
Priority number, dateUS20090174419P30.04.2009         Original published format: US 174419 P
[2012/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010127166
Date:04.11.2010
Language:EN
[2010/44]
Type: A2 Application without search report 
No.:EP2425001
Date:07.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.2010 takes the place of the publication of the European patent application.
[2012/10]
Search report(s)International search report - published on:KR10.03.2011
(Supplementary) European search report - dispatched on:EP11.10.2012
ClassificationIPC:C12N15/867, C12N15/49, C12N15/113, A61K39/21
[2012/10]
CPC:
C07K14/7158 (EP,US); A61K48/0066 (US); A61K31/7105 (US);
A61K38/53 (EP,US); A61P31/18 (EP); C12N15/1138 (EP,US);
C12N15/86 (EP,US); C12N7/00 (US); C12Y603/02 (EP,US);
C12N2310/14 (EP,US); C12N2310/141 (US); C12N2310/531 (EP,US);
C12N2320/31 (US); C12N2320/32 (US); C12N2740/16011 (US);
C12N2740/16043 (EP,US); C12N2740/16051 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/10]
TitleGerman:ANTI-HIV-KOMBINATIONSVEKTOREN, TARGETING-VEKTOREN UND ANWENDUNGSVERFAHREN[2012/10]
English:COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE[2012/10]
French:VECTEURS D'ASSOCIATION ANTI-VIH, VECTEURS DE CIBLAGE, ET PROCÉDÉS D'UTILISATION[2012/10]
Entry into regional phase28.11.2011National basic fee paid 
28.11.2011Search fee paid 
28.11.2011Designation fee(s) paid 
28.11.2011Examination fee paid 
Examination procedure28.11.2011Examination requested  [2012/10]
10.05.2013Amendment by applicant (claims and/or description)
25.06.2013Despatch of a communication from the examining division (Time limit: M06)
03.01.2014Reply to a communication from the examining division
27.02.2014Despatch of a communication from the examining division (Time limit: M06)
09.09.2014Reply to a communication from the examining division
22.09.2014Despatch of a communication from the examining division (Time limit: M01)
21.10.2014Reply to a communication from the examining division
05.12.2014Communication of intention to grant the patent
19.12.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.02.2015Communication of intention to grant the patent
24.06.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.08.2015Communication of intention to grant the patent
11.04.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.05.2016Communication of intention to grant the patent
21.09.2016Application deemed to be withdrawn, date of legal effect  [2017/12]
03.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2017/12]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.06.2013
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
11.04.2016Request for further processing filed
11.04.2016Full payment received (date of receipt of payment)
Request granted
25.04.2016Decision despatched
Fees paidRenewal fee
25.04.2012Renewal fee patent year 03
29.04.2013Renewal fee patent year 04
28.04.2014Renewal fee patent year 05
27.04.2015Renewal fee patent year 06
27.04.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2004094642  (SAN RAFFAELE CENTRO FOND [IT], et al) [A] 1-4,7-9,13-15 * the whole document *;
 [A]WO2005081911  (DANA FARBER CANCER INST INC [US], et al) [A] 1-4,7-9,13-15 * the whole document *;
 [X]WO2008109837  (CALIFORNIA INST OF TECHN [US], et al) [X] 1-4,7-9,13-15 * the whole document *;
 [A]WO2008150814  (REID CHRISTOPHER B [US]) [A] 1-4,7-9,13-15 * the whole document *;
 [X]  - ANDERSON J ET AL, "Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection", GENE THERAPY,, (20070901), vol. 14, no. 17, pages 1287 - 1297, XP002612770 [X] 1-4,7-9,13-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.gt.3302958
 [X]  - JOHN ROSSI, "RNAi as a treatment for HIV-1 infection", BIOTECHNIQUES, (20060401), vol. 40, no. S4, doi:10.2144/000112167, ISSN 0736-6205, pages S25 - S29, XP055011286 [X] 1-4,7-9,13-15 * the whole document *

DOI:   http://dx.doi.org/10.2144/000112167
 [XP]  - JOSEPH S ANDERSON ET AL, "Preintegration HIV-1 Inhibition by a Combination Lentiviral Vector Containing a Chimeric TRIM5[alpha] Protein, a CCR5 shRNA, and a TAR Decoy", MOLECULAR THERAPY, (20091201), vol. 17, no. 12, doi:10.1038/mt.2009.187, ISSN 1525-0016, pages 2103 - 2114, XP055038621 [XP] 1-4,7-9,13-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/mt.2009.187
International search[A]US2004248296  (BERESFORD PAUL J [US], et al);
 [A]WO2007000668  (SAN RAFFAELE CENTRO FOND [IT], et al);
 [A]US2007141679  (SODROSKI JOSEPH [US], et al);
 [X]US2008003682  (LOIS-CABALLE CARLOS [US], et al);
 [X]US2008227736  (CHEN IRVIN S Y [US], et al)
by applicantUS707993
 US4965204
 US5591624
 US5693508
 US5710037
 US5994108
 US6365150
 US6372502
 US6475786
 US6485929
 US2003013669
 US2004013167
 US6924123
 US6930174
 US6949243
 US2005271665
 US6995258
 US6995919
 US7056699
 US7070994
 US7122185
 US7160546
 US7175988
 US7252991
 US7262049
 US7419829
 US7442551
 US7501123
 US7521045
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.